ANALYTICS
medsim is turning simulation runs into auditable artifacts, not just fast ones.
Alternatives · analytics tools
invasimapr alternatives
The best invasimapr alternatives in analytics tools, ranked by Sparkpulse's velocity_score.
Updated Aug 17, 2026
Looking for the best alternatives to invasimapr? Sparkpulse tracks and ranks 12 alternatives in analytics tools by shipping velocity — how frequently each ships meaningful updates, verified from official changelogs. For reference, invasimapr shipped 0 meaningful updates in the last 30 days and carries a velocity score of 0.0 out of 10 in 2026. The alternatives below are ranked the same way, so you're comparing real release momentum, not marketing claims.
About invasimapr
invasimapr halved its install size and became citable; the science stayed put.
invasimapr estimates species invasiveness and site invasibility from trait, environmental and resident-community data, exposing a traits → competition → invasion-fitness pipeline behind seven high-level wrappers. Its three releases are all packaging and standards work: a first citable archive in June 2026, then a maturity release bringing it in line with the B-Cubed software development guide. The one behavioral addition in that release is an opt-in standardise_inputs argument on compute_invasion_fitness(), off by default.
Velocity 0.0 · Last update 24m ago
Top 12 alternatives to invasimapr
Ranked by recent ship velocity. Tap any card for the full editorial breakdown, or pivot to a head-to-head.
ANALYTICS
Rho's release machinery is now more rigorous than the product it ships.
ANALYTICS
aniprocess rebuilt its filter API into three tiers and removed the old one outright.
ANALYTICS
RMediation shipped a three-normal CDF, then found it was silently wrong.
ANALYTICS
clinify is closing the gap between flextable defaults and regulatory table specs.
ANALYTICS
b3gbi pulled confidence intervals out of its indicator workflow and handed them to dubicube.
ANALYTICS
soilDBdata exists so soilDB's tests can run without a NASIS connection.
ANALYTICS
collinear has broken its API twice to stop making the user pick thresholds.
ANALYTICS
nert put fourteen TERN datasets behind one dispatcher and called it stable.
ANALYTICS
scTypeEval judges single-cell annotations without needing a ground truth to judge them against.
ANALYTICS
medrobust made its partial-identification bounds usable by giving them confidence intervals.
ANALYTICS
probmed went from one probabilistic effect size to a family of them in sixteen days.
invasimapr vs alternatives — shipping velocity at a glance
Velocity score (0–10) and meaningful releases shipped in the last 30 days, from official changelogs. Higher = shipping faster.
| Product | Velocity | Sparks · 30d | Focus areas | Latest release |
|---|---|---|---|---|
| invasimapr (baseline) | 0.0 | 0 | invasion ecologyspecies traitsbiodiversity | — |
| medsim | 6.3 | 1 | mediation analysismonte carloreproducibility | medsim 0.5.0 — chunked-run integrity |
| Rho | 6.3 | 1 | r-ideai-agentsmodel-routing | Agent conversations and provider-routed models land in Rho |
| aniprocess | 3.8 | 1 | animal trackingsignal processingbreaking changes | Three-tier filter API; filter_aniframe() removed |
| rmediation | 3.8 | 1 | mediation analysisnumerical integrationcorrectness | v1.7.0 — pprodnormal3() correctness fix |
| clinify | 2.5 | 0 | clinical trialsregulatory reportingtable formatting | Document objects: clindoc() and multi-table output |
| b3gbi | 2.5 | 0 | biodiversitygbifuncertainty | Uncertainty split out of the indicator workflow into add_ci() |
| soilDBdata | 0.0 | 0 | soil datatest fixturesnasis | — |
| collinear | 0.0 | 0 | multicollinearityvariable selectionvif | Adaptive thresholds, multi-response support and a new output class |
| nert | 0.0 | 0 | environmental dataapi clientsoil data | nert 1.0.0 — first stable release |
| scTypeEval | 0.0 | 0 | single-cellcell type annotationbioconductor | — |
| medrobust | 0.0 | 0 | causal mediationpartial identificationmisclassification | Bounds corrected against oracles; Imbens-Manski intervals added |
| probmed | 0.0 | 0 | causal mediationeffect sizesemiparametric inference | Four estimator families on a cross-fitted corner-EIF core |
The 12 best invasimapr alternatives, in depth
1. medsim · velocity 6.3
Medsim is turning simulation runs into auditable artifacts, not just fast ones.
Over the last 30 days medsim shipped 1 meaningful update vs invasimapr's 0, most recently “medsim 0.5.0 — chunked-run integrity”. Its velocity score of 6.3/10 blends that with longer-term release cadence.
Where invasimapr leans on invasion ecology, species traits and biodiversity, medsim focuses on mediation analysis, monte carlo and reproducibility.
Over the last 30 days medsim has been shipping faster than invasimapr — a point in its favour if release momentum matters to you.
2. Rho · velocity 6.3
Rho's release machinery is now more rigorous than the product it ships.
Over the last 30 days Rho shipped 1 meaningful update vs invasimapr's 0, most recently “Agent conversations and provider-routed models land in Rho”. Its velocity score of 6.3/10 blends that with longer-term release cadence.
Where invasimapr leans on invasion ecology, species traits and biodiversity, Rho focuses on r ide, ai agents and model routing.
Over the last 30 days Rho has been shipping faster than invasimapr — a point in its favour if release momentum matters to you.
3. aniprocess · velocity 3.8
Aniprocess rebuilt its filter API into three tiers and removed the old one outright.
Over the last 30 days aniprocess shipped 1 meaningful update vs invasimapr's 0, most recently “Three-tier filter API; filter_aniframe() removed”. Its velocity score of 3.8/10 blends that with longer-term release cadence.
Where invasimapr leans on invasion ecology, species traits and biodiversity, aniprocess focuses on animal tracking, signal processing and breaking changes.
Over the last 30 days aniprocess has been shipping faster than invasimapr — a point in its favour if release momentum matters to you.
Full aniprocess trajectory → · Compare invasimapr vs aniprocess →
4. rmediation · velocity 3.8
RMediation shipped a three-normal CDF, then found it was silently wrong.
Over the last 30 days rmediation shipped 1 meaningful update vs invasimapr's 0, most recently “v1.7.0 — pprodnormal3() correctness fix”. Its velocity score of 3.8/10 blends that with longer-term release cadence.
Where invasimapr leans on invasion ecology, species traits and biodiversity, rmediation focuses on mediation analysis, numerical integration and correctness.
Over the last 30 days rmediation has been shipping faster than invasimapr — a point in its favour if release momentum matters to you.
Full rmediation trajectory → · Compare invasimapr vs rmediation →
5. clinify · velocity 2.5
Clinify is closing the gap between flextable defaults and regulatory table specs.
Its velocity score of 2.5/10 reflects longer-term release cadence; its most recent meaningful update was “Document objects: clindoc() and multi-table output”.
Where invasimapr leans on invasion ecology, species traits and biodiversity, clinify focuses on clinical trials, regulatory reporting and table formatting.
clinify and invasimapr have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
6. b3gbi · velocity 2.5
B3gbi pulled confidence intervals out of its indicator workflow and handed them to dubicube.
Its velocity score of 2.5/10 reflects longer-term release cadence; its most recent meaningful update was “Uncertainty split out of the indicator workflow into add_ci()”.
Where invasimapr leans on invasion ecology, species traits and biodiversity, b3gbi focuses on biodiversity, gbif and uncertainty.
b3gbi and invasimapr have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
7. soilDBdata · velocity 0.0
SoilDBdata exists so soilDB's tests can run without a NASIS connection.
Its velocity score of 0.0/10 reflects longer-term release cadence.
Where invasimapr leans on invasion ecology, species traits and biodiversity, soilDBdata focuses on soil data, test fixtures and nasis.
soilDBdata and invasimapr have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
Full soilDBdata trajectory → · Compare invasimapr vs soilDBdata →
8. collinear · velocity 0.0
Collinear has broken its API twice to stop making the user pick thresholds.
Its velocity score of 0.0/10 reflects longer-term release cadence; its most recent meaningful update was “Adaptive thresholds, multi-response support and a new output class”.
Where invasimapr leans on invasion ecology, species traits and biodiversity, collinear focuses on multicollinearity, variable selection and vif.
collinear and invasimapr have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
Full collinear trajectory → · Compare invasimapr vs collinear →
9. nert · velocity 0.0
Nert put fourteen TERN datasets behind one dispatcher and called it stable.
Its velocity score of 0.0/10 reflects longer-term release cadence; its most recent meaningful update was “nert 1.0.0 — first stable release”.
Where invasimapr leans on invasion ecology, species traits and biodiversity, nert focuses on environmental data, api client and soil data.
nert and invasimapr have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
10. scTypeEval · velocity 0.0
ScTypeEval judges single-cell annotations without needing a ground truth to judge them against.
Its velocity score of 0.0/10 reflects longer-term release cadence.
Where invasimapr leans on invasion ecology, species traits and biodiversity, scTypeEval focuses on single cell, cell type annotation and bioconductor.
scTypeEval and invasimapr have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
Full scTypeEval trajectory → · Compare invasimapr vs scTypeEval →
11. medrobust · velocity 0.0
Medrobust made its partial-identification bounds usable by giving them confidence intervals.
Its velocity score of 0.0/10 reflects longer-term release cadence; its most recent meaningful update was “Bounds corrected against oracles; Imbens-Manski intervals added”.
Where invasimapr leans on invasion ecology, species traits and biodiversity, medrobust focuses on causal mediation, partial identification and misclassification.
medrobust and invasimapr have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
Full medrobust trajectory → · Compare invasimapr vs medrobust →
12. probmed · velocity 0.0
Probmed went from one probabilistic effect size to a family of them in sixteen days.
Its velocity score of 0.0/10 reflects longer-term release cadence; its most recent meaningful update was “Four estimator families on a cross-fitted corner-EIF core”.
Where invasimapr leans on invasion ecology, species traits and biodiversity, probmed focuses on causal mediation, effect size and semiparametric inference.
probmed and invasimapr have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
Frequently asked questions
What are the best alternatives to invasimapr?
The top invasimapr alternatives we currently track in analytics tools are medsim, Rho, aniprocess, rmediation, clinify, ranked by recent ship velocity.
How is this list of invasimapr alternatives ranked?
Alternatives are ranked by Sparkpulse's velocity_score — release cadence + 30-day spark count + sector-relative ship rate.
Can I compare invasimapr directly with one of these alternatives?
Yes — every card has a "Compare with invasimapr" link to a side-by-side /compare page.